Adage Capital Partners’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Adage Capital Partners’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-225,000	Closed	-$8.09M	–	1090
2022 Q4	$8.09M	Buy	225,000 +25,000	+13%	+$625K	0.02%	688
2022 Q3	$3.01M	Sell	200,000 -25,000	-11%	-$406K	0.01%	829
2022 Q2	$3.01M	Sell	225,000 -50,000	-18%	-$794K	0.01%	856
2022 Q1	$5.3M	Hold	275,000	–	–	0.01%	824
2021 Q4	$6.52M	Sell	275,000 -119,586	-30%	-$2.77M	0.01%	785
2021 Q3	$7.9M	Buy	+394,586	New	+$8.47M	0.02%	764

Adage Capital Partners's IMGO Position: Q1 2023 in Review

Adage Capital Partners sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 225,000 shares — an estimated $8.09M sold.

Adage Capital Partners first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $8.09M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Adage Capital Partners reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Adage Capital Partners sold 225,000 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $8.09M.
Adage Capital Partners first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
Adage Capital Partners's Imago BioSciences, Inc. Common stock position peaked at $8.09M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Adage Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.